EDGAR Filing Documents for 0001144204-17-019040

Form 8-K - Current report:

SEC Accession No. 0001144204-17-019040

Filing Date

2017-04-05

Accepted

2017-04-05 06:01:03

Documents

Period of Report

2017-04-02

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	v463442_8k.htm	8-K	24251
2	EXHIBIT 4.1	v463442_ex4-1.htm	EX-4.1	93178
3	EXHIBIT 5.1	v463442_ex5-1.htm	EX-5.1	9711
4	EXHIBIT 10.1	v463442_ex10-1.htm	EX-10.1	210144
5	EXHIBIT 10.2	v463442_ex10-2.htm	EX-10.2	155067
6	EXHIBIT 10.3	v463442_ex10-3.htm	EX-10.3	18572
7	EXHIBIT 99.1	v463442_ex99-1.htm	EX-99.1	5144
8	EXHIBIT 99.2	v463442_ex99-2.htm	EX-99.2	10817
9	GRAPHIC	pg1img1_ex99-2.jpg	GRAPHIC	5472
	Complete submission text file	0001144204-17-019040.txt		535845

Mailing Address 1414 HARBOUR WAY SOUTH SUITE 1201 RICHMOND CA 94804

Business Address 1414 HARBOUR WAY SOUTH SUITE 1201 RICHMOND CA 94804 510-984-1761

EKSO BIONICS HOLDINGS, INC. (Filer) CIK: 0001549084 (see all company filings)